Yasuhiro Hiyoshi

445 total citations
28 papers, 329 citations indexed

About

Yasuhiro Hiyoshi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yasuhiro Hiyoshi has authored 28 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Yasuhiro Hiyoshi's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (13 papers) and Neuroendocrine Tumor Research Advances (7 papers). Yasuhiro Hiyoshi is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (13 papers) and Neuroendocrine Tumor Research Advances (7 papers). Yasuhiro Hiyoshi collaborates with scholars based in Japan. Yasuhiro Hiyoshi's co-authors include Satoshi Igawa, Jiichiro Sasaki, Masashi Kasajima, Tomoya Fukui, Masato Katagiri, Masaru Kubota, Katsuhiko Naoki, Sakiko Otani, Hisashi Mitsufuji and Noriyuki Masuda and has published in prestigious journals such as PLoS ONE, Annals of Oncology and BMC Cancer.

In The Last Decade

Yasuhiro Hiyoshi

27 papers receiving 326 citations

Peers

Yasuhiro Hiyoshi

ONCOL

PRM

EPIDE

IMMUN

Ying Cheng China

Norimitsu Kasahara Japan

Masashi Kasajima Japan

Keiko Tanimura Japan

Qing Chang China

Moises J. Velez United States

Margaux Geier France

Rui Kitadai Japan

Elisabetta Gambale Italy

Eriko Miyawaki Japan

Ying Cheng China

Yasuhiro Hiyoshi

211 ×0.8

ONCOL

102 ×0.5

PRM

59 ×0.9

EPIDE

64 ×1.2

31 ×1.2

IMMUN

Citations per year, relative to Yasuhiro Hiyoshi Yasuhiro Hiyoshi (= 1×) peers Ying Cheng

Countries citing papers authored by Yasuhiro Hiyoshi

Since Specialization

Citations

This map shows the geographic impact of Yasuhiro Hiyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Hiyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Hiyoshi more than expected).

Fields of papers citing papers by Yasuhiro Hiyoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Hiyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Hiyoshi. The network helps show where Yasuhiro Hiyoshi may publish in the future.

Co-authorship network of co-authors of Yasuhiro Hiyoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Hiyoshi. A scholar is included among the top collaborators of Yasuhiro Hiyoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Hiyoshi. Yasuhiro Hiyoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Igawa, Satoshi, Takaaki Ono, Tetsuya Ozawa, et al.. (2019). EP1.01-68 Impact of EGFR Genotype on the Efficacy of Osimertinib in Patients with Non-Small Cell Lung Cancer: A Prospective Observational Study. Journal of Thoracic Oncology. 14(10). S938–S938. 1 indexed citations

Igawa, Satoshi, Masashi Kasajima, Yasuhiro Hiyoshi, et al.. (2019). Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study. Cancer Management and Research. Volume 11. 4883–4892. 17 indexed citations

Shirasawa, Masayuki, Tomoya Fukui, Yasuhiro Hiyoshi, et al.. (2019). Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia. BMC Cancer. 19(1). 163–163. 5 indexed citations

Hiyoshi, Yasuhiro, Yuichi Sato, Masaaki Ichinoe, et al.. (2019). Prognostic significance of IMMT expression in surgically‐resected lung adenocarcinoma. Thoracic Cancer. 10(11). 2142–2151. 9 indexed citations

Fukui, Tomoya, Masashi Kasajima, Yasuhiro Hiyoshi, et al.. (2019). Questionnaire survey on patient awareness of invasive rebiopsy in advanced non‐small cell lung cancer. Thoracic Cancer. 10(3). 501–507. 4 indexed citations

Shirasawa, Masayuki, Tomoya Fukui, Yasuhiro Hiyoshi, et al.. (2019). Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer. PLoS ONE. 14(4). e0214599–e0214599. 28 indexed citations

Shirasawa, Masayuki, Tomoya Fukui, Yasuhiro Hiyoshi, et al.. (2018). Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer. Cancer Management and Research. Volume 10. 6039–6047. 18 indexed citations

Fukui, Tomoya, Yoshiro Nakahara, Sakiko Otani, et al.. (2018). Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non–Small-Cell Lung Cancer: A Prospective Observational Study. Clinical Lung Cancer. 20(3). 208–214.e2. 70 indexed citations

Fukui, Tomoya, Yoshiro Nakahara, Sakiko Otani, et al.. (2017). A prospective observational study of immune checkpoint inhibitor nivolumab treatment in patients with non-small cell lung cancer. Annals of Oncology. 28. x135–x135. 1 indexed citations

10.

Igawa, Satoshi, Sakiko Otani, Yoshiro Nakahara, et al.. (2017). Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non–small cell lung cancer. Investigational New Drugs. 36(1). 45–52. 3 indexed citations

11.

Igawa, Satoshi, Yuichi Sato, Shinichiro Ryuge, et al.. (2017). Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer. Oncology. 92(5). 283–290. 34 indexed citations

12.

Ryuge, Shinichiro, Yuichi Sato, Ryo Nagashio, et al.. (2017). Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers. PLoS ONE. 12(3). e0173886–e0173886. 7 indexed citations

13.

Igawa, Satoshi, Sakiko Otani, Shinichiro Ryuge, et al.. (2017). Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer. Investigational New Drugs. 35(5). 642–648. 4 indexed citations

14.

Shirasawa, Masayuki, Yoshiro Nakahara, Masashi Kasajima, et al.. (2016). Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small-cell lung cancer. Molecular and Clinical Oncology. 5(6). 714–716. 4 indexed citations

15.

Shirasawa, Masayuki, Masaru Kubota, Masashi Kasajima, et al.. (2016). Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case report. Lung Cancer. 99. 66–68. 13 indexed citations

16.

Fukui, Tomoya, Yasuhiro Hiyoshi, Masashi Kasajima, et al.. (2016). Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer. BMC Cancer. 16(1). 197–197. 19 indexed citations

17.

Igawa, Satoshi, Nobuyuki Yanagisawa, Yasuhiro Hiyoshi, et al.. (2015). Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report. Oncology Letters. 10(6). 3519–3522. 8 indexed citations

18.

Igawa, Satoshi, Masashi Kasajima, Michiko Kimura, et al.. (2014). Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutation. Cancer Chemotherapy and Pharmacology. 74(5). 939–946. 10 indexed citations

19.

Igawa, Satoshi, Masashi Kasajima, Michiko Kimura, et al.. (2014). Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation. Oncology. 87(4). 215–223. 12 indexed citations

20.

Igawa, Satoshi, Jiichiro Sasaki, Sakiko Otani, et al.. (2013). Evaluation of Amrubicin as a Third or Later Line of Chemotherapy for Advanced Non-Small Cell Lung Cancer. Chemotherapy. 59(2). 99–105. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact